Andrew Hill Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,934
Closed -$5.18M 61
2025
Q4
$5.18M Buy
8,934
+18
+0.2% +$10.2K 3.94% 11
2025
Q3
$4.32M Buy
8,916
+3,502
+65% +$1.63M 3.36% 14
2025
Q2
$2.2M Buy
+5,414
New +$2.26M 1.77% 24
2025
Q1
Sell
-2,938
Closed -$1.53M 58
2024
Q4
$1.53M Buy
+2,938
New +$1.62M 1.14% 28
2022
Q3
$2.46M Buy
4,844
+656
+16% +$367K 3.33% 16
2022
Q2
$2.27M Sell
4,188
-653
-13% -$359K 3.27% 12
2022
Q1
$2.86M Sell
4,841
-117
-2% -$67.2K 3.17% 12
2021
Q4
$3.31M Buy
+4,958
New +$3.1M 3.09% 14

Other funds holding TMO

Andrew Hill Investment Advisors's TMO Position: Q1 2026 in Review

Andrew Hill Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 8,934 shares — an estimated $5.18M sold.

Andrew Hill Investment Advisors first reported a position in TMO in Q4 2021 and held it in 8 quarters. The position peaked at $5.18M in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Andrew Hill Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Andrew Hill Investment Advisors sold 8,934 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.18M.
  • Andrew Hill Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 8 quarters.
  • Andrew Hill Investment Advisors's Thermo Fisher Scientific position peaked at $5.18M in Q4 2025.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Andrew Hill Investment Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.